NUGL P / E
Was ist das P / E von NUGL?
P / E von NUGL, Inc. ist N/A
Was ist die Definition von P / E?
Das Terminkurs-Gewinn-Verhältnis ist das Verhältnis des Aktienkurses eines Unternehmens zum geschätzten Gewinn des Unternehmens je Aktie für die nächsten zwölf Monate.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P / E von Unternehmen in Technology Sektor auf OTC im Vergleich zu NUGL
Was macht NUGL?
NUGL Inc. operates as a vertically integrated medical cannabis company. It operates cultivation facility, processing facility, three retail dispensaries, conditional licenses, and supplies and exports medical cannabis primarily in the Caribbean, Australia, and South America. The company was founded in 2018 and is based in Kingston, Jamaica.
Unternehmen mit p / e ähnlich NUGL
- Happy Valley Nutrition hat P / E von N/A
- Maple Peak Investments hat P / E von N/A
- co.don AG hat P / E von N/A
- BioVie hat P / E von N/A
- BioVie hat P / E von N/A
- Relmada Therapeutics hat P / E von N/A
- NUGL hat P / E von N/A
- Greencastle Resources hat P / E von N/A
- Astra Exploration Inc hat P / E von N/A
- Pharmadrug hat P / E von N/A
- Blackwolf Copper and Gold hat P / E von N/A
- Burnpur Cement hat P / E von N/A
- Exopharm hat P / E von N/A